GE HealthCare Q4 revenue up 7.1% to $5.7B; 2026 EPS guidance $4.95-$5.15

GE HealthCare Technologies Inc.

2025-FY EPS reported $4.55 vs consensus $1.43 ▲ beat (+219.0%)

Q4 revenue $5.7B (+7.1% YoY, organic +4.8%); diluted EPS $1.29, adjusted EPS $1.44.
Full year revenue $20.6B (+4.8%); diluted EPS $4.55, adjusted EPS $4.59; free cash flow $1.5B.
2026 guidance: organic revenue growth 3-4%, adj. EPS $4.95-$5.15, adj. EBIT margin 15.8-16.1%.
Q4 net income $589M vs $720M prior; margins compressed due to tariff expense and unfavorable mix.
Acquiring Intelerad for $2.3B, expected close H1 2026; closed Nihon Medi-Physics and icometrix in 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.